Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Inactivated vs Live-attenuated Hepatitis A Vaccine in Thai Children
NCT06298708Phase 3Completed
- Sponsor
- Chiang Mai University
- Start
- Apr 2024
- Primary completion
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis A vaccine (H2 strain) in hepatitis A (HAV), sponsored by Chiang Mai University. Started Apr 2024; status: completed.
02
Drugs
hepatitis A vaccine (H2 strain)
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT06298708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06298708.